Skip to main content

Wakefit Innovations To Review Q1 Results On August 6

Wakefit Innovations will review its Q1 FY27 results on August 6, 2026. The D2C home and sleep solutions brand, which listed in December 2025, previously closed its trading window on July 1, 2026, in anticipation of the board meeting. This meeting follows a strong FY26 performance where the company turned profitable with a net profit of ₹189.18 crore.

Author Image
Sahi Markets
Published: 31 Jul 2026, 04:25 PM IST (1 hour ago)
Last Updated: 31 Jul 2026, 04:25 PM IST (1 hour ago)
3 min read
Reviewed by Arpit Seth

Market snapshot: Wakefit Innovations Limited has scheduled a meeting of its Board of Directors on August 6, 2026, to consider and approve the un-audited financial results for the first quarter ended June 30, 2026. This announcement marks the company's first-quarter earnings update following its stock exchange listing in December 2025.

Data Snapshot

  • Revenue from Operations for Q4 FY26 stood at ₹343.6 crore, representing a 13.5% YoY growth from ₹302.61 crore.
  • Net profit for Q4 FY26 turned positive at ₹121.75 crore, compared to a net loss of ₹26.2 crore in Q4 FY25.
  • Full-year FY26 Revenue from Operations grew 16.9% YoY to ₹1,488.94 crore from ₹1,273.69 crore in FY25.

What's Changed

  • Wakefit's bottom-line performance turned from a net loss of ₹35 crore in FY25 to a net profit of ₹189.18 crore in FY26, showcasing a major operational turnaround.
  • The quarterly EBITDA margin expanded to 15.7% in Q4 FY26 from 4.8% in Q4 FY25.

Key Takeaways

  • Board Meeting Scheduled: The Board of Directors will meet on August 6, 2026, to review and approve the un-audited quarterly results.
  • Trading Window Closure: In compliance with insider trading regulations, the trading window was closed on July 1, 2026, and will reopen 48 hours post the result announcement.
  • Strong Base from FY26: The company enters Q1 FY27 on a strong footing after turning profitable in FY26 with a full-year net profit of ₹189.18 crore.

SAHI Perspective

Wakefit's turnaround in FY26 was heavily aided by a one-time deferred tax asset of ₹98.07 crore, though operating performance also improved with revenue growing at 16.9% YoY. In the upcoming Q1 FY27 results, investors must monitor whether the company can maintain organic profitability and manage raw material price volatility, particularly key inputs like Polyol and TDI which experienced a price hike in early 2026.

Market Implications

A strong Q1 FY27 result would bolster investor confidence in the newly listed D2C player, helping it compete more effectively against traditional mattress and furnishing majors like Sheela Foam. Conversely, any margin compression due to elevated raw material costs or aggressive promotional discounts could put pressure on the stock.

Trading Signals

Market Bias: Neutral

The stock remains neutral ahead of the board meeting on August 6, 2026, where Q1 results will be declared. While FY26 showed a strong turnaround with ₹189.18 crore PAT, investors are waiting to see if this operating momentum continues into Q1 FY27 without one-time tax benefits.

Overweight: Home Furnishing, D2C Brands

Trigger Factors:

  • Un-audited Q1 FY27 financial results announcement on August 6, 2026.
  • Operating EBITDA margin expansion or compression trends.
  • Management commentary on raw material cost inflation (Polyol/TDI).

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian modern mattress and home furnishing market is highly competitive, with a mix of organized and unorganized players. Wakefit, which operates a vertically integrated D2C model, competes with established brands like Sheela Foam (makers of Sleepwell) and Duroflex. Branded players are focusing on omnichannel expansion and product diversification to capture market share.

Key Risks to Watch

  • Raw Material Volatility: Sharp increases in the prices of key raw materials like Polyol and TDI can severely impact gross margins.
  • Competitor Spend: High cost intensity and elevated marketing spend by competitors in the home durables segment could compress margins.
  • Deferred Tax Base: FY26 net profit was boosted by a ₹98.07 crore deferred tax asset; core operational profit needs to sustain.

Recent Developments

In July 2026, Wakefit Innovations approved a grant of 4,57,611 Employee Stock Options (ESOPs) to eligible employees under its 2019 plan. In the same month, the Bombay Stock Exchange (BSE) sought clarification from Wakefit Innovations regarding a significant movement in its trading volume.

Closing Insight

Wakefit's transition from an online-first D2C startup to a listed omnichannel enterprise has been marked by rapid revenue growth. The upcoming Q1 FY27 results will provide the first real test of its post-IPO steady-state profitability.

High Performance Trading with SAHI.

Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.

Open Free Account

Frequently Asked Questions (FAQs)

All topics